fluorodeoxyglucose f18 has been researched along with Carcinoma, Intraepithelial in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, N; Hama, N; Harada, S; Matsuura, Y; Munakata, K; Ota, H; Sato, H; Shimaoka, T; Takachi, K; Takiuchi, D; Wada, N | 1 |
| Fukui, M; Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K; Tsushima, Y | 1 |
| Bomanji, JB; Brown, J; Capitanio, A; Carroll, B; Falzon, M; Fraioli, F; George, PJ; Groves, AM; Janes, SM; Kayani, I; Navani, N; Smith, LJ; Thakrar, RM | 1 |
| Higure, A; Hirata, K; Inoue, Y; Katsuki, T; Konishi, T; Nagata, J; Nagata, N; Nagata, T; Nakayama, Y; Okamoto, K; Shibao, K; Tsurudome, Y; Yamaguchi, K | 1 |
| Doki, Y; Eguchi, H; Kim, T; Kitagawa, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Takeda, Y; Tanemura, M; Tatsumi, M; Tomimaru, Y; Umeshita, K; Wakasa, K | 1 |
| Bartsch, DK; Fendrich, V; Jacobsen, ID; Maitra, A; Opfermann, T; Schneider, R | 1 |
| Baker, JA; Coleman, RE; Rosen, EL; Soo, MS; Turkington, TG | 1 |
| Bomanji, J; Ell, PJ; George, PJ; Groves, AM; Kayani, I | 1 |
| Abbey, CK; Borowsky, AD; Cardiff, RD; Cherry, SR; Gregg, JP | 1 |
| Anscher, MS; Hebert, ME; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
| Boyd, J; Dunphy, F; Kim, HJ; Lowe, V | 1 |
| Boyd, JH; Dunphy, FR; Eisenbeis, JF; Fletcher, JW; Kim, H; Lowe, VJ | 1 |
| Berlangieri, SU; Clarke, CP; Fitt, GJ; Hennessy, OF; Knight, SR; McKay, WJ; Scott, AM; Tochon-Danguy, HJ | 1 |
| Avril, N; Bense, S; Dose, J; Graeff, H; Kuhn, W; Rosé, CA; Schelling, M; Schwaiger, M; Weber, W; Ziegler, S | 1 |
| Avril, N; Dose, J; Jänicke, F; Menzel, M; Nathrath, W; Schelling, M; Schwaiger, M; Weber, W | 1 |
| Burcombe, RJ; Emmott, J; Lowe, J; Makris, A; Pittam, M; Wong, WL | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.
Topics: Animals; Carcinoma in Situ; Carcinoma, Ductal, Breast; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Longitudinal Studies; Lymphatic Metastasis; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Whole-Body Counting | 2006 |
2 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
13 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
[A Case of Conversion Surgery for Gallbladder Cancer with Para-Aortic Lymph Node Metastasis].
Topics: Aged; Carcinoma in Situ; Cisplatin; Deoxycytidine; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes | 2023 |
Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma in Situ; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Positive (18)Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Predicts Preinvasive Endobronchial Lesion Progression to Invasive Cancer.
Topics: Aged; Aged, 80 and over; Bronchial Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
[A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET].
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography | 2008 |
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Carcinoma in Situ; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Genetic Engineering; Glucose; Glucose Transporter Type 2; Humans; Mice; Mice, Transgenic; Pancreatic Neoplasms; Positron-Emission Tomography; Precancerous Conditions | 2011 |
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Imaging bronchial carcinoma in situ: possible roles for combined positron emission tomography (PET)-CT.
Topics: Aged; Carcinoma in Situ; Carcinoma, Bronchogenic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography | 2005 |
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
Topics: Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Cicatrix; Deoxyglucose; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Diseases; Lung Neoplasms; Neoplasm, Residual; Prospective Studies; Remission Induction; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1998 |
Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Topics: Carcinoma in Situ; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cords | 1999 |
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Topics: Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2002 |